Christian Ott

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial

Melvin D. Lobo, Paul A. Sobotka, Alice Stanton et al. · The Lancet · 2015 · 176 citations · Full text

Hypertension, Blood Pressure, Cardiovascular Disease +8

New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans

Joanna Haraźny, Ulrike Raff, Jürgen Welzenbach et al. · Journal of Hypertension · 2011 · 64 citations

Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease

Giovańni Ciuffetti, Michele Mercuri, Christian Ott et al. · European Journal of Clinical Pharmacology · 1991 · 55 citations

Inflammation, Vascular Pharmacology, Pharmacology +8

Central pulse pressure predicts BP reduction after renal denervation in patients with treatment-resistant hypertension

Christian Ott, Axel Schmid, Stefan W. Toennes et al. · EuroIntervention · 2015 · 52 citations